Dong et al. developed a glioma-targeted drug delivery system utilizing biodegradable periodic mesoporous organosilica nanoparticles modified with Lf ligands, enhancing drug delivery to brain gliomas [15]. The gene discussed is LTF; the disease is central nervous system cancer.